Curis
CRIS
#10201
Rank
HK$0.13 B
Marketcap
HK$10.51
Share price
0.00%
Change (1 day)
-65.82%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): -HK$28.58

According to Curis's latest financial reports the company's current EPS (TTM) is -HK$28.56. In 2024 the company made an earnings per share (EPS) of -HK$54.71 an increase over its 2023 EPS that were of -HK$70.19.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$28.58-47.76%
2024-HK$54.71-22.06%
2023-HK$70.19-26.25%
2022-HK$95.1722.3%
2021-HK$77.82-25.37%
2020-HK$104.28-30.93%
2019-HK$150.97-2.02%
2018-HK$154.08
2016-HK$350.18-10%
2015-HK$389.09138.1%
2014-HK$163.4240%
2013-HK$116.73-25%
2012-HK$155.6466.67%
2011-HK$93.38

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Exelixis
EXEL
HK$18.52-164.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$10.97-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-HK$2.80-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$26.30-7.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$13.38-146.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$23.11-180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-HK$87.47 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA